1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Epiomic Epidemiology Series: Idiopathic Pulmonary Fibrosis Forecast in 9 Major Markets 2015-2025

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Idiopathic Pulmonary Fibrosis in 9 Major Markets

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause. The disease is idiopathic, although a number of possible causes have been identified, including exposure to various dusts and smoking. This report provides the current prevalent population for IPF across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a breakdown of the course of the disease, progressive vs. stable, with the definite diagnosed IPF patient population. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of IPF have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for IPF include:

-GORD
-Cardiovascular Disease
-Presence of clubbing
-Air ventilation assistance

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global IPF market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of IPF and identify patient segments with high potential. This would include patients diagnosed with definite or probable IPF.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on IPF’s prevalent population.
-Identify sub-populations within IPF which require treatment.
-Gain an understanding of the specific markets that have the largest number of IPF patients.

Table Of Contents

Epiomic Epidemiology Series: Idiopathic Pulmonary Fibrosis Forecast in 9 Major Markets 2015-2025
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/ Ethnicity
-Disease Prognosis and Clinical Course
-Key Co-Morbid Conditions / Features associated with the Disease
-Methodology for Quantification of Patient Numbers
o Additional data available on request
-Top-Line Prevalence for Idiopathic Pulmonary Fibrosis
o Type of IPF
o GAP Staging
o Co-morbid Conditions in IPF
o Air Ventilation Assistance in IPF Patients
-Abbreviations used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix

List of Tables and Figures
-GAP Index for IPF Staging
-Gap Staging System
-Prevalence of IPF, total (000s)
-Prevalence of IPF, males (000s)
-Prevalence of IPF, females (000s)
-Type of IPF present in patients, total (000s)
-Course of disease in definite IPF patients, total (000s)
-GAP stages in patients with definite IPF, total (000s)
-GORD in patients with IPF, total (000s)
-Presence of clubbing in patients with IPF, total (000s)
-Cardiovascular disease in patients with IPF, total (000s)
-Supplemental oxygen use in patients with IPF, total (000s)
-Abbreviations and Acronyms used in the report
-USA Prevalence of IPF by 5-yr age cohort, males (000s)
-USA Prevalence of IPF by 5-yr age cohort, females (000s)
-France Prevalence of IPF by 5-yr age cohort, males (000s)
-France Prevalence of IPF by 5-yr age cohort, females (000s)
-Germany Prevalence of IPF by 5-yr age cohort, males (000s)
-Germany Prevalence of IPF by 5-yr age cohort, females (000s)
-Italy Prevalence of IPF by 5-yr age cohort, males (000s)
-Italy Prevalence of IPF by 5-yr age cohort, females (000s)
-Spain Prevalence of IPF by 5-yr age cohort, males (000s)
-Spain Prevalence of IPF by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of IPF by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of IPF by 5-yr age cohort, females (000s)
-Brazil Prevalence of IPF by 5-yr age cohort, males (000s)
-Brazil Prevalence of IPF by 5-yr age cohort, females (000s)
-Japan Prevalence of IPF by 5-yr age cohort, males (000s)
-Japan Prevalence of IPF by 5-yr age cohort, females (000s)
-India Prevalence of IPF by 5-yr age cohort, males (000s)
-India Prevalence of IPF by 5-yr age cohort, females (000s)



View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.